Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
Muhlenberg’s Department of Mathematics, Computer Science, and Statistics challenges students to […]
From the moment these five students stepped onto campus, they challenged themselves to make the […]
Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.